Investors

Growing Shareholder Value

Press Releases

FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology

Oct 26, 2020
Read More
Additional Formats
PDF Version

Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP

Oct 16, 2020
Read More
Additional Formats
PDF Version

Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival, Particularly in Women

Oct 16, 2020
Read More
Additional Formats
PDF Version

Abiomed to Host a Virtual Meeting to Discuss New Clinical Data Presented at TCT Connect

Oct 15, 2020
Read More
Additional Formats
PDF Version

Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes

Oct 15, 2020
Read More
Additional Formats
PDF Version

Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

Oct 14, 2020
Read More
Additional Formats
PDF Version

Abiomed Second Quarter Fiscal 2021 Earnings and Conference Call Notification

Oct 08, 2020
Read More
Additional Formats
PDF Version

TCT Connect to Highlight How Impella Enables Improved Outcomes for High-Risk PCI, Cardiogenic Shock and Right Heart Failure Patients

Oct 08, 2020
Read More
Additional Formats
PDF Version

Abiomed to Hold Fireside Chat at the Raymond James North American Equities Conference

Sep 14, 2020
Read More
Additional Formats
PDF Version

Abiomed to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthcare Conference

Sep 08, 2020
Read More
Additional Formats
PDF Version
View all